The Market Access process in Ireland looks simple. However, in reality the timeline of the HTA process is usually unpredictable and there are significant delays in post-HTA recommendation due to limited government staff capacity and drug budget.

Today is the annual International Day of Immunology. That might once have been largely of interest to immunologists, but we are all immunologists now. The arrival of SARS-CoV-2 has changed the way the world looks at immunology.

Unlike other European healthcare systems, Switzerland does not have a free state-run healthcare system. Instead, health insurance is compulsory and is run primarily by the private sector.

The UK’s plastic packaging tax finally rolled into action on 1^st April 2022. Manufacturers and importers of plastic packaging containing less than 30% recycled plastic content will now be taxed at a rate of £200 per metric tonne.

Introduced in 2014, EAMS aims to give patients with life-threatening or seriously debilitating conditions access to medicines when there is a clear unmet need. The scheme is voluntary and does not replace the normal licensing procedures.

Rare Disease Day is a globally coordinated patient-led movement working towards equity in social opportunity, healthcare, and access to therapies for people affected by rare diseases. Read this blog to learn more about the day and about MAP’s vital work in accelerating patient access for rare diseases.

Healthcare in Canada has been identified as being fragmented, and obtaining Market Access is cumbersome and lengthy. Rare diseases are a complex issue but account for a large amount of healthcare spending. Currently there is no orphan medicine framework in Canada. Planned changes announced by the Patented Medicines Pricing and Review Board (PMPRB) to promote fair and equal pricing to medicines, may see the prices of drugs for rare diseases being reduced significantly, making Canada a less attractive market for pharma in the future.

It was 10 years ago that Christian Hill co-founded MAP with his wife Dawn. Their mission was to transform healthcare Market Access to reach patients sooner with innovative medicines and devices. This year marks 10 years since MAP was founded, read this blog to find out how we are celebrating this milestone year.

It has been another challenging year living through a global pandemic, but MAP is proud to have grown and continues to support clients and their patients. The team have reflected on this past year and what is coming next as we move into our 10th year. Read our thoughts in our latest blog.

This blog discusses what Health Economics is, what Health Economists do and the Health Economic Evaluation (HEE).

Pharmaceutical companies and NICE should consider early patient engagement for health technology appraisals, as discussed at the MAP Patient Conference.